Neurol. praxi. 2012;13(3):171-173

Lambert-Eaton myasthenic syndrome in a child

MUDr.Jan Staněk1, MUDr.František Vlček2
1 Klinika dětské neurologie FN Ostrava
2 Neurologická klinika FN Ostrava

Lambert-Eaton myasthenic syndrome is a rare autoimunne presynaptic disorder of neuromuscular transmission. It is characterised by

muscle weakness, hyporeflexia and autonomic dysfunction. The syndrome is often associated with small cell lung carcinomas. It is a disease

of middle and older age. Rare cases have been reported in children. We present a 12-year boy with abnormal gait, slight bilateral

ptosis, hyporeflexia, xerostomia and vitiligo without evidence of neoplasms. High- frequency repetitive nerve stimulation with a large

increment and a P/Q- type calcium- channel antibodies level confirmed the diagnosis of the syndrome. Corticosteroids, azathioprine

and pyridostigmine improved patient´s weakness.

Keywords: Lambert-Eaton myasthenic syndrome, weakness, xerostomia, calcium- channels, increment, vitiligo

Published: May 31, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Staněk J, Vlček F. Lambert-Eaton myasthenic syndrome in a child. Neurol. praxi. 2012;13(3):171-173.
Download citation

References

  1. Ambler Z. Neurofyziologie a elektrodiagnostika nervosvalového přenosu. Neurol. praxi 2010; 11: 81-84.
  2. Anderson HJ, Churchill-Davidson HC, Richardson AT. Bronchial neoplasm with myasthenia; prolonged apnoea after administration of succinylcholine. Lancet 1953; 265: 1291-1293. Go to original source... Go to PubMed...
  3. Bednařík J, Voháňka S, Ehler E, Ambler Z, Piťha J, Vencovský J, Litzman J, Kořístek Z, Suchý M, Pátá M, Kožený P. Standard pro léčbu pacientů s autoimunitními nervosvalovými onemocněními intravenozním lidským imunoglobulinem a plazmaferézou. Cesk Slov Neurol N 2010; 73: 579-589.
  4. Hoffman WH, Helman SW, Sekul E, Caroll JE, Vega RA. Lambert-Eaton Myasthenic Syndrome in a Child With an Autoimmune Phenotype. Amer J Med Genet Part A 2003; 119A, 1: 77-80. Go to original source... Go to PubMed...
  5. Kostera-Pruszczyk A, Ryniewicz B, Rowinska-Marcinska K, Dutkiewicz M, Kamińska A. Lambert-Eaton myasthenic syndrome in childhood. Eur J Paediatr Neuro 2009; 13: 194-196. Go to original source... Go to PubMed...
  6. Lambert EH, Eaton LM, Rooke ED. Defect of neuromuscular conduction associated with malignant neoplasms. Am J Physiol 1956; 187: 612-613.
  7. Lang B, Newsom-Davis J. Immunopathology of the Lambert-Eaton myasthenic syndrome. Springer Seminars in Immunopathology 1995; 17: 3-15. Go to original source... Go to PubMed...
  8. Menkes JH, Sarnat HB, Maria BL. Dětská neurologie. Praha: Triton 2011: 1564.
  9. Nakashima I, Kikuchi A, Onodera J, Shiga Y, Fujihara K, Motomura M, Itoyama Y. A juvenile case of Lambert-Eaton myastenic syndrome with severe emaciation. Rinsho Shinkeigaku 1997; 37: 402-406. Go to PubMed...
  10. Shapira Y, Cividalli G, Szabo G. A myasthenic syndrome in childhood leukemia. Dev Med Child Neurol 1974; 6: 668-671. Go to original source... Go to PubMed...
  11. Takamori M. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis. J Neuroimmunol. 2008; 15: 201-202. Go to original source... Go to PubMed...
  12. Tsao CY, Mendell JR, Friemer ML, Kissel JT. Lambert-Eaton Myasthenic Syndrome in Children. J Child Neurol 2002; 17: 74-76. Go to original source... Go to PubMed...
  13. Tsuchiya N, Sato M, Uesaka Y, Kurose N, Haida M, Nakano J, Tsuchida T, Inoue T, Ito K. Lambert-Eaton Myasthenic Syndrome Associated with Sjögren´s Syndrome and Discoid Lupus Erythematosus. Scand J Rheumatol 1993; 22: 302-304. Go to original source... Go to PubMed...
  14. Wirtz PW, Wintzen AR, Verschuuren JJ. The Lambert-Eaton myasthenic syndrome has a more progressive course in patients with lung cancer. Muscle and Nerve 2005; 32: 226-229. Go to original source... Go to PubMed...
  15. Wirtz PW, Smallegange TM, Wintzen AR, Verschuuren JJ. Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases. Clin Neurol Neurosurg 2002; 104: 359-363. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.